Figure 3. A PcnaK164R mutation renders lymphomas highly sensitive to CsPt treatment.
(A) Representative examples of DDTP or DDTD tumor bearing mice at the beginning (right), and at the end of the CsPt treatment (left). (B) Kaplan – Meier curve of mice carrying DDTP or DDTD tumors. **p = 0.0011 by Mantel-Cox test when comparing DDTP or DDTD tumor bearing mice treated with CsPt. Treated groups received 6 mg/kg CsPt every two weeks, starting from the first bioluminescent signal detection by IVIS.